Manufacturers Life Insurance Company, The Regenxbio Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Regenxbio Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 17,928 shares of RGNX stock, worth $172,646. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,928
Previous 18,375 2.43%
Holding current value
$172,646
Previous $214,000 12.15%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$10.49 - $14.39 $4,689 - $6,432
-447 Reduced 2.43%
17,928 $188,000
Q2 2024

Aug 14, 2024
BUY
$11.51 - $21.53 $34,702 - $64,912
3,015 Added 19.63%
18,375 $214,000
Q1 2024

May 14, 2024
SELL
$12.17 - $24.61 $7,265 - $14,692
-597 Reduced 3.74%
15,360 $323,000
Q4 2023

Feb 13, 2024
SELL
$12.89 - $20.82 $5,478 - $8,848
-425 Reduced 2.59%
15,957 $286,000
Q2 2023

Aug 11, 2023
SELL
$17.23 - $21.71 $211,257 - $266,186
-12,261 Reduced 42.81%
16,382 $327,000
Q1 2023

May 15, 2023
SELL
$18.08 - $24.55 $233,991 - $317,726
-12,942 Reduced 45.18%
15,701 $296,000
Q4 2022

Aug 11, 2023
SELL
$20.4 - $24.73 $126,479 - $153,326
-6,200 Reduced 17.79%
28,643 $649,000
Q4 2022

Feb 13, 2023
SELL
$20.4 - $24.73 $126,479 - $153,326
-6,200 Reduced 17.79%
28,643 $649,000
Q3 2022

Aug 11, 2023
SELL
$22.29 - $35.04 $1,270 - $1,997
-57 Reduced 0.16%
34,843 $920,000
Q3 2022

Nov 03, 2022
SELL
$22.29 - $35.04 $1,270 - $1,997
-57 Reduced 0.16%
34,843 $893,000
Q2 2022

Aug 11, 2023
BUY
$19.35 - $35.04 $52,573 - $95,203
2,717 Added 8.44%
34,900 $862,000
Q2 2022

Aug 15, 2022
BUY
$19.35 - $35.04 $52,573 - $95,203
2,717 Added 8.44%
34,900 $854,000
Q1 2022

Aug 11, 2023
BUY
$24.62 - $34.31 $405,786 - $565,497
16,482 Added 104.97%
32,183 $1.07 Million
Q1 2022

May 20, 2022
BUY
$24.62 - $34.31 $289,038 - $402,799
11,740 Added 57.43%
32,183 $1.07 Million
Q4 2021

Feb 16, 2022
SELL
$30.19 - $40.28 $10,657 - $14,218
-353 Reduced 1.7%
20,443 $666,000
Q3 2021

Nov 12, 2021
SELL
$29.09 - $45.68 $49,336 - $77,473
-1,696 Reduced 7.54%
20,796 $872,000
Q2 2021

Aug 12, 2021
BUY
$32.46 - $40.48 $11,718 - $14,613
361 Added 1.63%
22,492 $874,000
Q1 2021

May 03, 2021
BUY
$33.61 - $49.95 $48,263 - $71,728
1,436 Added 6.94%
22,131 $755,000
Q4 2020

Feb 12, 2021
BUY
$26.52 - $49.35 $17,025 - $31,682
642 Added 3.2%
20,695 $939,000
Q3 2020

Nov 09, 2020
SELL
$27.01 - $40.26 $9,399 - $14,010
-348 Reduced 1.71%
20,053 $552,000
Q2 2020

Aug 10, 2020
SELL
$27.75 - $43.44 $25,890 - $40,529
-933 Reduced 4.37%
20,401 $754,000
Q1 2020

May 15, 2020
BUY
$21.5 - $54.2 $24,918 - $62,817
1,159 Added 5.74%
21,334 $691,000
Q4 2019

Feb 14, 2020
SELL
$34.54 - $44.87 $20,033 - $26,024
-580 Reduced 2.79%
20,175 $827,000
Q3 2019

Nov 12, 2019
SELL
$31.84 - $50.88 $573 - $915
-18 Reduced 0.09%
20,755 $692,000
Q2 2019

Aug 14, 2019
SELL
$42.0 - $59.29 $8,316 - $11,739
-198 Reduced 0.94%
20,773 $1.07 Million
Q1 2019

May 13, 2019
BUY
$40.82 - $62.45 $55,800 - $85,369
1,367 Added 6.97%
20,971 $1.2 Million
Q4 2018

Feb 14, 2019
SELL
$39.11 - $75.15 $34,886 - $67,033
-892 Reduced 4.35%
19,604 $822,000
Q3 2018

Nov 14, 2018
SELL
$65.0 - $82.15 $45,695 - $57,751
-703 Reduced 3.32%
20,496 $1.55 Million
Q2 2018

Aug 14, 2018
BUY
$27.2 - $74.35 $5,712 - $15,613
210 Added 1.0%
21,199 $1.52 Million
Q1 2018

May 15, 2018
SELL
$24.05 - $37.5 $4,401 - $6,862
-183 Reduced 0.86%
20,989 $627,000
Q4 2017

Feb 08, 2018
BUY
$26.0 - $34.6 $4,472 - $5,951
172 Added 0.82%
21,172 $703,000
Q3 2017

Nov 14, 2017
BUY
$18.0 - $32.95 $378,000 - $691,950
21,000
21,000 $692,000

Others Institutions Holding RGNX

# of Institutions
197
Shares Held
43.2M
Call Options Held
104K
Put Options Held
478K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $416M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email